Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 5/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 5/20 | 0.34 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.32 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23593054 | 1.00 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10CYP3A4KDM4E | |
| SCHEMBL23593091 | 0.99 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10CYP3A4KDM4E | |
| SCHEMBL23593048 | 0.97 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL23593055 | 0.97 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL23593053 | 0.94 | MMP12 (0.32) | PLA2G2APLA2G4AKDM4EMEN1KMT2A | |
| SCHEMBL23593046 | 0.94 | ANO1 (0.32) | PLA2G2APLA2G4A | |
| SCHEMBL23593340 | 0.93 | ANO1 (0.33) | PLA2G2APLA2G4AKMT2AMAPK1ABCG2 | |
| SCHEMBL23593049 | 0.93 | ANO1 (0.33) | PLA2G2APLA2G4AKMT2AMAPK1ABCG2 | |
| SCHEMBL23593092 | 0.92 | PLA2G2A (0.32) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL23592407 | 0.91 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230048456-A1 | ORGANIC LIGHT-EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER THEREOF | LT MATERIALS CO., LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| US-20230016632-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
| WO-2021132930-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | 엘티소재주식회사 | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230016632-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP1B1, CRY1 | PLA2G2A 4002/4885PLA2G4A 4030/4885PLA2G10 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.